Table 1. Concordance rates between phenotypic antimicrobial susceptibility and genotype with the presence of resistance genes or mutation
Ann Clin Microbiol 2022;25:119-124. Predicting phenotypic antimicrobial resistance in Escherichia coli isolates, using whole genome sequencing data Download table Concordance rates: % (n/n)* GM-R CP-R SXT-R TET-R CIP-R aac(3′)-IIa: 100 (1/1) catA1: 100% (2/2) sul only: 3 (1/35) tet(A): 99 (82/83) parC: 50 (1/2) aac(3)-IId: 100 (2/2) catB3: 100% (3/3) sul2: 0 (0/32) tet(A)+tet(B): 100 […]
Table 4. Agreement & error rates between QMAC-dRAST and Vitek 2* for each antimicrobial agent
Ann Clin Microbiol 2022;25:109-118. Clinical usefulness of the QMAC-dRAST system for AmpC β-lactamase-producing Enterobacterales Download table Antimicrobial agents Total No. of tested isolates EA (%) CA (%) VME (%) ME (%) mE (%) Amikacin 80 100.0 100.0 0 0 0 Amoxicillin/Clavulanate 80 96.3 91.3 3.8 0 5.0 Ampicillin 80 98.8 98.8 0 50.0 0 Aztreonam […]
Table 3. The number of AST results and agreement & error rates between QMAC-dRAST and Vitek 2* for each bacterial species
Ann Clin Microbiol 2022;25:109-118. Clinical usefulness of the QMAC-dRAST system for AmpC β-lactamase-producing Enterobacterales Download table Bacterial species No. of AST results No. of susceptibility category in Vitek 2† EA CA VME ME mE R I S No. (%) No. (%) No. (%) No. (%) No. (%) M. morganii 280 88 12 180 257 (91.8) […]
Table 2. The number of agreement & error categories with the BMD test for isolates showing discrepancies between QMAC-dRAST and Vitek 2
Ann Clin Microbiol 2022;25:109-118. Clinical usefulness of the QMAC-dRAST system for AmpC β-lactamase-producing Enterobacterales Download table Bacterial species No. of AST results No. of susceptibility category in BMD No. of agreement & error categories QMAC-dRAST vs. BMD Vitek 2 vs. BMD R I S EA CA VME ME mE EA CA VME ME mE M. […]
Table 1. Comparison of agreement & error rates between QMAC-dRAST and Vitek 2* before and after AST algorithm optimization
Ann Clin Microbiol 2022;25:109-118. Clinical usefulness of the QMAC-dRAST system for AmpC β-lactamase-producing Enterobacterales Download table Bacterial species No. of AST results Before algorithm optimization (%) After algorithm optimization (%) CA VME ME mE CA VME ME mE M. morganii 120 67.5 25.8 17.9 17.5 79.2 0 7.1 15.8 S. marcescens 120 42.5 0 55.6 […]
Table 3. AstraZeneca ChAdOx1 seropositive rate and quantitative level of immunoglobin according to Elecsys COV2S and Centaur COV2T
Ann Clin Microbiol 2022;25:85-95. Antibody detection in healthcare workers after vaccination with two doses of the BNT162b2 or ChAdOx1 vaccine Download table Quantitation U/mL AstraZeneca ChAdOx1 – post 3 weeks AstraZeneca ChAdOx1 – post 16 weeks Male (n = 38) Female (n = 78) Total (n = 116) Male (n = 21) Female […]
Table 2. Pfizer BNT162b2 seropositive rate and quantitative level of immunoglobin according to Elecsys COV2S and Centaur COV2T
Ann Clin Microbiol 2022;25:85-95. Antibody detection in healthcare workers after vaccination with two doses of the BNT162b2 or ChAdOx1 vaccine Download table Quantitation U/mL Pfizer BNT162b2 – post 3 weeks Pfizer BNT162b2 – post 16 weeks Male (n = 40) Female (n = 78) Total (n = 118) Male (n = 40) Female […]
Table 1. Demographic data of Pfizer and AstraZeneca vaccine groups
Ann Clin Microbiol 2022;25:85-95. Antibody detection in healthcare workers after vaccination with two doses of the BNT162b2 or ChAdOx1 vaccine Download table Demographic data Pfizer BNT162b2 AstraZeneca ChAdOx1 Sex Male Female Total Male Female Total 41 (33.9) 80 (66.1) 121 (100.0) 38 (32.5) 79 (67.5) 117 (100.0) Age (yr) […]
Table 2. Antimicrobial susceptibility patterns of 23 C. striatum isolates
Ann Clin Microbiol 2022;25:79-84. Antimicrobial susceptibility patterns and clinical characteristics of Corynebacterium striatum cases from 2018 to 2021 Download table Isolates Minimum inhibitory concentration (ug/mL) and interpretation Penicillin G Cefotaxime Meropenem Erythromycin Ciprofloxacin Trimethoprim/Sulfamethoxazole Vancomycin 1 > 32 R NT > 32 R 64 R NT > 32 R 0.75 S 2 1 S NT […]
Table 1. Clinical features and outcome of C. striatum cases between 2018 and 2021
Ann Clin Microbiol 2022;25:79-84. Antimicrobial susceptibility patterns and clinical characteristics of Corynebacterium striatum cases from 2018 to 2021 Download table Demographic data Pfizer BNT162b2 AstraZeneca ChAdOx1 Sex Male Female Total Male Female Total 41 (33.9) 80 (66.1) 121 (100.0) 38 (32.5) 79 (67.5) 117 (100.0) Age (yr) 20 – 29 5 (12.2) 19 (23.8) 24 […]